Parallax Volatility Advisers
CCXI

Parallax Volatility Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Parallax Volatility Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-62,400
Closed -$155K – 3793
2016
Q1 		$155K Hold
62,400
– – ﹤0.01% 1843
2015
Q4 		$505K Buy
+62,400
New +$442K ﹤0.01% 1540

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Parallax Volatility Advisers's CCXI Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q1 2018, closing a stake of 3,738 shares — an estimated $22K sold.

Parallax Volatility Advisers first reported a position in CCXI in Q4 2015 and held it in 3 quarters. The position peaked at $491K in Q4 2015. 100 funds tracked by Wall St. Rank hold CCXI as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining ChemoCentryx, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,738 ChemoCentryx, Inc. shares in Q1 2018, an estimated $22K.
  • Parallax Volatility Advisers first reported a position in ChemoCentryx, Inc. in Q4 2015 and held it in 3 quarters.
  • Parallax Volatility Advisers's ChemoCentryx, Inc. position peaked at $491K in Q4 2015.
  • 100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.